Appili Therapeutics

(OTC) APLIF

Current Price$0.01

Market Cap$1.52M

Since IPO (2020)-99%

5 Year-98%

1 Year-15%

1 Month-18%

Appili Therapeutics Financials at a Glance

Market Cap

$1.52M

Revenue (TTM)

CA$206.22K

Net Income (TTM)

-CA$2.96M

EPS (TTM)

-$0.02

P/E Ratio

-0.69

Dividend

$0.00

Beta (Volatility)

0.47 (Low)

Dividend

$0.00

Beta (Volatility)

0.47 (Low)

Price

$0.01

Volume

6,800

Open

$0.01

Price

$0.01

Volume

6,800

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

Estimated Earnings Date

Jul 1, 2026

Dividend

$0.00

Beta (Volatility)

0.47 (Low)

Price

$0.01

Volume

6,800

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

Estimated Earnings Date

Jul 1, 2026

APLIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Appili Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Don Cilla, MBA

Website

www.appilitherapeutics.com

Headquarters

Halifax, NS B3H 0A8, CA

APLIF Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-15%

Net Income Margin

-14%

Return on Equity

Return on Capital

20%

Return on Assets

-5%

Earnings Yield

-1.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.52M

Shares Outstanding

128.37M

Volume

6.80K

Avg. Volume

22.59K

Financials (TTM)

Gross Profit

CA$100.44K

Operating Income

-CA$190.84K

EBITDA

CA$360.57K

Operating Cash Flow

CA$868.82K

Capital Expenditure

-CA$2.36K

Free Cash Flow

CA$866.46K

Cash & ST Invst.

CA$1.23M

Total Debt

CA$12.29M

Appili Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

CA$114.89K

+6.0%

Gross Profit

CA$115.01K

+6.1%

Gross Margin

1.00%

N/A

Market Cap

$1.52M

N/A

Market Cap/Employee

$190.30K

N/A

Employees

N/A

Net Income

-CA$948.73K

-80.9%

EBITDA

-CA$716.73K

-8635.2%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

-CA$12.24M

-10.3%

Accounts Receivable

CA$179.01K

-89.8%

Inventory

CA$0.00

N/A

Long Term Debt

CA$736.20K

-9.3%

Short Term Debt

CA$11.71M

+11.9%

Return on Assets

-5.40%

N/A

Return on Invested Capital

20.00%

N/A

Free Cash Flow

-CA$292.83K

+33.9%

Operating Cash Flow

-CA$292.83K

+33.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AGNPFAlgernon Pharmaceuticals Inc.

AGNPFAlgernon Pharmaceuticals Inc.$0.34+6.63%

HESGHealth Sciences Group, Inc.

HESGHealth Sciences Group, Inc.$0.00+0.00%

AAGHAmerica Great Health

AAGHAmerica Great Health$0.00+0.00%

VGLSSB Technology Holdings, Inc.

VGLSSB Technology Holdings, Inc.$0.40+0.00%

RGBPRegen BioPharma, Inc.

RGBPRegen BioPharma, Inc.$0.00+0.00%

IBOGFUniversal Ibogaine Inc.

IBOGFUniversal Ibogaine Inc.$0.03-7.05%

ADXSAyala Pharmaceuticals, Inc.

ADXSAyala Pharmaceuticals, Inc.$0.60+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

MRVLMarvell Technology

MRVLMarvell Technology$263.47-0.17%

Questions About APLIF

What is the current price of Appili Therapeutics?

Appili Therapeutics is trading at $0.01 per share.

What is the 52-week range for Appili Therapeutics?

Over the past 52 weeks, Appili Therapeutics has traded between $0.01 and $0.03.

How much debt does Appili Therapeutics have?

As of the most recent reporting period, Appili Therapeutics reported total debt of CA$9.09M.

How much cash does Appili Therapeutics have on hand?

Appili Therapeutics reported CA$155.21K in cash and cash equivalents in its most recent financial results.

What is Appili Therapeutics’s dividend yield?

Appili Therapeutics does not currently have a dividend yield.

Appili Therapeutics

Appili Therapeutics Financials at a Glance

APLIF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Appili Therapeutics

APLIF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Appili Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About APLIF

What is the current price of Appili Therapeutics?

What is the 52-week range for Appili Therapeutics?

How much debt does Appili Therapeutics have?

How much cash does Appili Therapeutics have on hand?

What is Appili Therapeutics’s dividend yield?

Premium Investing Services